Chylothorax is caused by disruption of the thoracic duct and distributor resulting in chyli (lymphatics fluid of interstitial region) into pleural space.Â This can be seen in many conditions, and trauma and malignancy are the leading causes. The diagnosis based on pleural fluid can be made by demonstration of triglycerides of more than 110 mg/dL or the presence of chylomicrons. Various surgical and nonsurgical management strategies can be used for the treatment of chylothorax. Currently, somatostatin analogs are effectively used for its treatment.